(ALK-B) ALK-Abelló - Performance 16.8% in 12m
Compare ALK-B with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
27.29%
#21 in Group
Rel. Strength
71.84%
#2247 in Universe
Total Return 12m
16.77%
#41 in Group
Total Return 5y
87.29%
#23 in Group
P/E 39.9
77th Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -0.28%
80th Percentile in Group
12m Total Return: ALK-B (16.8%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: ALK-B vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALK-B
Total Return (including Dividends) | ALK-B | XBI | S&P 500 |
---|---|---|---|
1 Month | 8.65% | 5.55% | -0.45% |
3 Months | -2.92% | -9.75% | -6.29% |
12 Months | 16.77% | -5.39% | 13.04% |
5 Years | 87.29% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | ALK-B | XBI | S&P 500 |
1 Month | 80.4% | 70% | 47.5% |
3 Months | -61.9% | -88.1% | -87.3% |
12 Months | -16.8% | -44.4% | 54.3% |
5 Years | 25.7% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #99 | 2.94% | 9.14% |
3 Month | #65 | 7.58% | 3.61% |
12 Month | #43 | 23.4% | 3.30% |
5 Years | #23 | 116% | -11.6% |
FAQs
Does ALK-B ALK-Abelló outperforms the market?
Yes,
over the last 12 months ALK-B made 16.77%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months ALK-B made -2.92%, while XBI made -9.75%.
Over the last 3 months ALK-B made -2.92%, while XBI made -9.75%.
Performance Comparison ALK-B vs Indeces and Sectors
ALK-B vs. Indices ALK-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 2.28% | 9.10% | -4.78% | 3.73% |
US NASDAQ 100 | QQQ | 1.36% | 6.75% | -5.49% | 1.80% |
US Dow Jones Industrial 30 | DIA | 2.82% | 11.5% | -4.02% | 7.50% |
German DAX 40 | DAX | 2.64% | 8.87% | -22.9% | -8.24% |
Shanghai Shenzhen CSI 300 | CSI 300 | 5.93% | 11.9% | -1.08% | 11.8% |
Hongkong Hang Seng | HSI | 2.68% | 10.2% | -5.31% | 3.84% |
India NIFTY 50 | INDA | 4.80% | 3.77% | -4.66% | 13.9% |
Brasil Bovespa | EWZ | 3.91% | 5.82% | -10.5% | 23.5% |
ALK-B vs. Sectors ALK-B is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 2.13% | 9.25% | -10.8% | -6.69% |
Consumer Discretionary | XLY | 2.25% | 9.24% | -5.95% | 2.10% |
Consumer Staples | XLP | 4.34% | 9.47% | -8.88% | 5.83% |
Energy | XLE | 6.54% | 22.7% | 0.36% | 26.1% |
Financial | XLF | 3.39% | 10.7% | -11.7% | -5.90% |
Health Care | XLV | 4.98% | 13.3% | 0.38% | 18.0% |
Industrial | XLI | 1.96% | 8.35% | -5.82% | 6.08% |
Materials | XLB | 4.09% | 11.9% | 3.06% | 21.2% |
Real Estate | XLRE | 2.39% | 9.75% | -4.94% | -1.59% |
Technology | XLK | 0.72% | 6.22% | -1.83% | 6.33% |
Utilities | XLU | 3.56% | 8.55% | -9.20% | -4.02% |
Aerospace & Defense | XAR | 1.25% | 1.67% | -18.7% | -10.7% |
Biotech | XBI | 2.44% | 3.10% | 10.5% | 22.2% |
Homebuilder | XHB | 3.55% | 10.7% | 10.2% | 22.9% |
Retail | XRT | 3.52% | 9.81% | 1.18% | 18.3% |